-
COMPARATIVE EFFICACY AND SAFETY OF ORFORGLIPRON VS SGLT-2 INHIBITORS FOR THE TREATMENT OF INSUFFICIENTLY CONTROLLED TYPE 2 DIABETES AS AN ADD-ON TO BACKGROUND THERAPY OF 1-2 ORAL ANTIDIABETIC DRUGS: A NETWORK META-ANALYSIS
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF THE THERAPEUTIC PATHWAY WITH THE BARRX™ RADIOFREQUENCY ABLATION SYSTEM FOR BARRETT'S ESOPHAGUS, GASTRIC ANTRAL VASCULAR ECTASIA, AND RADIATION-INDUCED PROCTITIS IN THE ITALIAN NATIONAL HEALTH SERVICE
Aug 11, 2026, 17:16 PM -
HTA METHODOLOGICAL ADAPTATIONS FOR RARE DISEASES AND ORPHAN DRUGS: A REVIEW OF GLOBAL FRAMEWORKS AND CONSIDERATIONS FOR LATIN AMERICA
Aug 11, 2026, 17:16 PM -
A HYBRID AI-ASSISTED SCREENING FRAMEWORK FOR SYSTEMATIC LITERATURE REVIEWS IN ACUTE ISCHAEMIC STROKE-LARGE VESSEL OCCLUSION: EFFICIENCY AND ACCURACY
Aug 11, 2026, 17:16 PM -
GOVERNMENT AND COMPULSORY HEALTH FINANCING AND HOUSEHOLD OUT-OF-POCKET PAYMENT IN CENTRAL AND EASTERN EUROPE: A COMPARATIVE ANALYSIS, 2014-2023
Aug 11, 2026, 17:16 PM -
DEVELOPMENT OF AN ONLINE EVIDENCE GENERATION SUPPORT TOOL FOR DIGITAL HEALTH TECHNOLOGY DEVELOPERS: PRELIMINARY RESULTS FROM THE ASSESS DHT PROJECT
Aug 11, 2026, 17:16 PM -
HEALTH-RELATED QUALITY OF LIFE BURDEN ASSOCIATED WITH PAST-YEAR DEPRESSION IN THE EU5: A MATCHED NATIONAL HEALTH AND WELLNESS SURVEY ANALYSIS
Aug 11, 2026, 17:16 PM -
CKM-KG: A UNIFIED CARDIOVASCULAR-KIDNEY-METABOLIC KNOWLEDGE GRAPH FOR EVIDENCE INTEGRATION, WITH HYPERTENSION AS A CASE STUDY
Aug 11, 2026, 17:16 PM -
COMPARING THE PSYCHOMETRIC PERFORMANCE OF FOUR FATIGUE-RELATED EQ-5D-5L BOLT-ONS IN A MULTINATIONAL, LONGITUDINAL GENERAL POPULATION SETTING
Aug 11, 2026, 17:16 PM -
ADVANCING THE ASSESSMENT OF DIGITAL HEALTH INNOVATION - LESSONS DRAWN FROM A CATALOGUE OF AI USE CASES
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF CYP3A5 GENOTYPE-GUIDED TACROLIMUS DOSING IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: A MONTE CARLO SIMULATION FROM AN INDIAN HEALTHCARE PERSPECTIVE
Aug 11, 2026, 17:16 PM -
BRIDGING THE GAP FROM SURROGATE TO HARD OUTCOMES IN C3 GLOMERULOPATHY: A BAYESIAN SURVIVAL MODELING FRAMEWORK TO PREDICT THE LONG-TERM IMPACT OF IPTACOPAN ON END-STAGE RENAL DISEASE (ESRD) FREE SURVIVAL
Aug 11, 2026, 17:16 PM -
A POPULATION-BASED DATA LINKAGE APPROACH TO STUDY FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA: OVERCOMING DATA FRAGMENTATION
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF MALARIA PREVENTION STRATEGIES IN CHILDREN UNDER FIVE IN HIGH-ENDEMIC SETTINGS
Aug 11, 2026, 17:16 PM -
CHRONIC KIDNEY DISEASE PREVENTION INVESTMENT BY STAGE: WHERE SCREENING SAVES THE MOST AND WHY
Aug 11, 2026, 17:16 PM -
REAL-WORLD EVIDENCE ON ORAL CLADRIBINE IN MULTIPLE SCLEROSIS: CLINICAL EFFECTIVENESS, TREATMENT PATTERNS AND ECONOMIC BURDEN
Aug 11, 2026, 17:16 PM -
TYPE 2 DIABETES AND FRACTURE RISK IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN: A CHINESE COHORT STUDY
Aug 11, 2026, 17:16 PM -
METHODOLOGICAL RESERVATIONS IN RECENT FRENCH CEESP ECONOMIC OPINIONS: WHAT CHARACTERISES THE MOST CHALLENGING SUBMISSIONS
Aug 11, 2026, 17:16 PM -
RECAST-DEMENTIA: A REGISTER-BASED ECONOMIC COST AND SEQUENCE TRANSFORMER FOR DEMENTIA CARE COST FORECASTING USING SWEDISH REGISTER DATA
Aug 11, 2026, 17:16 PM -
OPERATIONALISING VALUE-BASED PRICING FOR ADVANCED THERAPY MEDICINAL PRODUCTS IN BRAZIL: A MULTI-STAKEHOLDER WORKSHOP INFORMING THE REVISION OF THE NATIONAL DRUG PRICING FRAMEWORK
Aug 11, 2026, 17:16 PM
